Chronic obstructive pulmonary disease (COPD) is the third most common cause of death by disease in the United States and one of the costliest diseases to treat, with no cure at present. More than 300 million people worldwide suffer from COPD. Current and former smokers, especially the older segments of the population, are most likely to suffer from it. In addition, it’s a common source of billing and reimbursement issues, with a high rate of readmission.
Given these grim facts, it is naturally the focus of a great deal of research and, fortunately, recent advancements have been made in understanding this very common disease. Notably, a recent study at Kanazawa Medical University (see Yamamura, Nishiki, et al., 2022) found a genetic component to the disease. Non-genetic conditions, notably tobacco use and to a lesser degree, environmental pollutants, are the primary causes of COPD, however, there may be a genetic aspect to the severity of the illness. A tumor suppressor called p53 normally appears in lung tissue in the presence of oxidative stress, inhibiting the reproduction tumor cells and triggering their destruction. In some COPD cases, a polymorphism occurs in p53 codon 72, and in patients carrying that genotype, a greater percentage of low-attenuation areas was found, along with greater airflow limitation and muscle atrophy. While the exact correlation, if any, between p53 polymorphism and COPD severity remains under investigation, this may be a significant step in understanding the root causes of the most severe cases.
Another advancement in understanding may point toward the eventual development of better medical COPD treatments. Researchers at the University of Technology, Sydney, have pinned down a biological component that may become a drug target. An enzyme secreted by mast cells in the immune system, mast cell chymase-1, was found by researchers to worsen the development of COPD. Levels of chymase-1 in COPD patients were found to be double that of the amount found in people without the disease. After determining an analogous enzyme in the immune system of mice, researchers showed that inhibiting the enzyme offered protection against inflammation, emphysema, and other aspects of the illness.
Other advances in COPD treatment are coming from the tech sector. Remote monitoring, telehealth, and health-related apps all skyrocketed in use during the pandemic, and it’s likely we will see an uptick in software solutions to monitor a wide range of health concerns. A company called Wellinks recently partnered with a clinic group in Connecticut to try to curb COPD readmissions through monitoring devices and an app. According to the company’s press release, they seek to combine “virtual pulmonary rehabilitation, personalized health coaching and monitoring through connected devices and a patient-friendly app to create a truly integrated approach to COPD management.” They hope that with communication and monitoring, readmissions—which are costly to all involved—can be decreased significantly.
While the data needs to be updated about the accuracy of remote CT readings—studies in the last decade showed a pretty hefty margin of error—the technology continues to advance. A study published in the American Journal of Roentgenology showed the ability of an artificial intelligence tool to detect an interstitial pulmonary embolus (iPE). The study shows that out of 40 iPEs detected in the team’s study sample, seven of them were detected only by the clinical reports, while AI detected four missed by clinicians. The study doesn’t speak on the idea of AI taking over altogether, and that is likely a long way off if it will ever happen. But it’s not unreasonable to see that AI could successfully serve as a secondary reader.
Thanksgiving, a cherished American holiday celebrated annually on the fourth Thursday of November, is synonymous with family gatherings, gratitude, and indulgent feasting. While it holds
Please log in to your account to comment on this article.
Sepsis sequencing continues to challenge even experienced coding and CDI professionals, with evolving guidelines, documentation gaps, and payer scrutiny driving denials and data inconsistencies. In this webcast, Payal Sinha, MBA, RHIA, CCDS, CDIP, CCS, CCS-P, CCDS-O, CRC, CRCR, provides clear guideline-based strategies to accurately code sepsis, severe sepsis, and septic shock, assign POA indicators, clarify the relationship between infection and organ dysfunction, and align documentation across teams. Attendees will gain practical tools to strengthen audit defensibility, improve first-pass accuracy, support appeal success, reduce denials, and ensure accurate quality reporting, empowering organizations to achieve consistent, compliant sepsis coding outcomes.
Expert presenters Kathy Pride, RHIT, CPC, CCS-P, CPMA, and Brandi Russell, RHIA, CCS, COC, CPMA, break down complex fracture care coding rules, walk through correct modifier application (-25, -57, 54, 55), and clarify sequencing for initial and subsequent encounters. Attendees will gain the practical knowledge needed to submit clean claims, ensure compliance, and stay one step ahead of payer audits in 2026.
Accurately determining the principal diagnosis is critical for compliant billing, appropriate reimbursement, and valid quality reporting — yet it remains one of the most subjective and error-prone areas in inpatient coding. In this expert-led session, Cheryl Ericson, RN, MS, CCDS, CDIP, demystifies the complexities of principal diagnosis assignment, bridging the gap between coding rules and clinical reality. Learn how to strengthen your organization’s coding accuracy, reduce denials, and ensure your documentation supports true medical necessity.
Denials continue to delay reimbursement, increase administrative burden, and threaten financial stability across healthcare organizations. This essential webcast tackles the root causes—rising payer scrutiny, fragmented workflows, inconsistent documentation, and underused analytics—and offers proven, data-driven strategies to prevent and overturn denials. Attendees will gain practical tools to strengthen documentation and coding accuracy, engage clinicians effectively, and leverage predictive analytics and AI to identify risks before they impact revenue. Through real-world case examples and actionable guidance, this session empowers coding, CDI, and revenue cycle professionals to shift from reactive appeals to proactive denial prevention and revenue protection.
In this timely session, Stacey Shillito, CDIP, CPMA, CCS, CCS-P, CPEDC, COPC, breaks down the complexities of Medical Decision Making (MDM) documentation so providers can confidently capture the true complexity of their care. Attendees will learn practical, efficient strategies to ensure documentation aligns with current E/M guidelines, supports accurate coding, and reduces audit risk, all without adding to charting time.
Join Ronald Hirsch, MD, FACP, CHCQM for The PEPPER Returns – Risk and Opportunity at Your Fingertips, a practical webcast that demystifies the PEPPER and shows you how to turn complex claims data into actionable insights. Dr. Hirsch will explain how to interpret key measures, identify compliance risks, uncover missed revenue opportunities, and understand new updates in the PEPPER, all to help your organization stay ahead of audits and use this powerful data proactively.
Stay ahead of the 2026-2027 audit surge with “Top 10 Audit Targets for 2026-2027 for Hospitals & Physicians: Protect Your Revenue,” a high-impact webcast led by Michael Calahan, PA, MBA. This concise session gives hospitals and physicians clear insight into the most likely federal audit targets, such as E/M services, split/shared and critical care, observation and admissions, device credits, and Two-Midnight Rule changes, and shows how to tighten documentation, coding, and internal processes to reduce denials, recoupments, and penalties. Attendees walk away with practical best practices to protect revenue, strengthen compliance, and better prepare their teams for inevitable audits.
As AI reshapes healthcare compliance, the risk of biased outputs and opaque decision-making grows. This webcast, led by Frank Cohen, delivers a practical Four-Pillar Governance Framework—Transparency, Accountability, Fairness, and Explainability—to help you govern AI-driven claim auditing with confidence. Learn how to identify and mitigate bias, implement robust human oversight, and document defensible AI review processes that regulators and auditors will accept. Discover concrete remedies, from rotation protocols to uncertainty scoring, and actionable steps to evaluate vendors before contracts are signed. In a regulatory landscape that moves faster than ever, gain the tools to stay compliant, defend your processes, and reduce liability while maintaining operational effectiveness.
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
